Related Experiment Video

Updated: Aug 20, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Immune-based therapies for prostate cancer

Douglas G McNeel1, Miroslav Malkovsky

  • 1Department of Medicine, University of Wisconsin Medical School, 600 Highland Avenue, Madison, WI 53792, USA. dm3@medicine.wisc.edu

Immunology Letters
|December 9, 2004
PubMed

Insights

Immunotherapy offers a promising new avenue for treating prostate cancer, a major cause of death. Recent advancements in active and passive immunotherapy suggest a hopeful future when combined with traditional treatments.

Area of Science:

  • Oncology
  • Immunology

Background:

  • Prostate cancer is a significant cause of morbidity and mortality in the United States.
  • Early studies over four decades ago indicated potential benefits of immunological approaches for prostate cancer treatment.

Purpose of the Study:

  • To explore advancements in immune-based therapy for prostate cancer.
  • To review current immunotherapy approaches and their potential combination with conventional therapies.

Main Methods:

  • Review of animal and clinical studies.
  • Analysis of information gathered over the last two decades on immune-based therapy.
  • Evaluation of current clinical trials and future treatment strategies.

Main Results:

  • Immunological approaches have evolved significantly over the past two decades.
  • Both passive and active immunotherapy strategies are being developed for prostate cancer.
  • Current trials show promise, especially when immunotherapy is combined with conventional treatments.

Conclusions:

  • The field of immune-based therapy for prostate cancer has advanced considerably.
  • Combining immunotherapy with conventional therapies offers a hopeful outlook for improved patient outcomes.
  • Further research and clinical trials are essential to fully realize the potential of immunotherapy in prostate cancer treatment.

More Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...